id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0169-0005,FDA,FDA-2006-N-0169,Use of Ozone-Depleting Substances; Removal of Essential Use Designations; Confirmation of Effective Date,Notice,Notice of Final Rule,2007-04-27T04:00:00Z,2007,4,2007-04-27T04:00:00Z,,2025-07-01T22:45:57Z,E7-8043,0,0,090000648045090f
FDA-2006-N-0169-0004,FDA,FDA-2006-N-0169,Finding of No Significant Impact (FONSI) for Removing the Essential-Use Designation Under 21 CFR 2.125 for the Following Human Drug Products,Supporting & Related Material,Finding of no Significant Impact,2007-01-25T05:00:00Z,2007,1,,,2025-07-01T22:58:10Z,,0,0,090000648045090d
FDA-2006-N-0169-0003,FDA,FDA-2006-N-0169,Environmental Assessment for Removing the Essential-Use Designation Under 21 CFR 2.125 for the Following Human Drug Products,Supporting & Related Material,Environmental Assessment,2007-01-25T05:00:00Z,2007,1,,,2025-07-01T22:55:27Z,,0,0,090000648045090c